Virtual Tour
Media
NEWS
Contact Us
Patients
NEUROLOGY
CinnoVex
ReciGen
CinnoMer
CinnoTec
ONCOLOGY & HAEMATOLOGY
PegaGen
CinnaPoietin
KidiPeg
GYNECOLOGY & HORMONE
Cinnal-f
CinnaFact
CinnaTropin
Melitide
RHEUMATOLOGY
CinnoPar
CinnoRA
KidiMab
Healthcare Professionals
NEUROLOGY
CinnoVex
ReciGen
CinnoMer
CinnoTec
ONCOLOGY & HAEMATOLOGY
PegaGen
CinnaPoietin
KidiPeg
GYNECOLOGY & HORMONE
Cinnal-f
CinnaTropin
CinnaFact
Melitide
RHEUMATOLOGY
CinnoPar
KidiMab
CinnoRA
Capabilities
Our Technology
Business Development
Our Manufacturing Sites
Research and Development
About Us
Presidential Note
About CinnaGen
Mission Statement
Policy
Management Team
Search
Virtual Tour
Media
NEWS
Contact Us
                   Â
CinnaGen ilac has been established in 2019
This company is the first full cycle manufacturing site to produce biosimilars in Turkey.
June2019 / PR /
Previuos News
Happy New Year
Next News
Happy New Year
tags:
cinnagen ilac
CinnaGen ilaç
More in this category:
CinnaGen ilaç
20Jan 2017
Home
CinnaGen ilac has been established in 2019
Back top Top
